AU645092B2 - Anti-actinic agent - Google Patents

Anti-actinic agent

Info

Publication number
AU645092B2
AU645092B2 AU78657/91A AU7865791A AU645092B2 AU 645092 B2 AU645092 B2 AU 645092B2 AU 78657/91 A AU78657/91 A AU 78657/91A AU 7865791 A AU7865791 A AU 7865791A AU 645092 B2 AU645092 B2 AU 645092B2
Authority
AU
Australia
Prior art keywords
actinic
agent
actinic agent
nicotinamide
systemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU78657/91A
Other languages
English (en)
Other versions
AU7865791A (en
Inventor
Gerhard Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU7865791A publication Critical patent/AU7865791A/en
Application granted granted Critical
Publication of AU645092B2 publication Critical patent/AU645092B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal (AREA)
  • Prostheses (AREA)
  • Glass Compositions (AREA)
AU78657/91A 1990-06-13 1991-05-24 Anti-actinic agent Ceased AU645092B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4018964A DE4018964C1 (enExample) 1990-06-13 1990-06-13
DE4018964 1990-06-13

Publications (2)

Publication Number Publication Date
AU7865791A AU7865791A (en) 1992-01-07
AU645092B2 true AU645092B2 (en) 1994-01-06

Family

ID=6408360

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78657/91A Ceased AU645092B2 (en) 1990-06-13 1991-05-24 Anti-actinic agent

Country Status (8)

Country Link
EP (1) EP0486632B1 (enExample)
JP (1) JPH0635387B2 (enExample)
AT (1) ATE108993T1 (enExample)
AU (1) AU645092B2 (enExample)
CA (1) CA2059641A1 (enExample)
DE (2) DE4018964C1 (enExample)
ES (1) ES2061248T3 (enExample)
WO (1) WO1991019478A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341001A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Topische Zubereitungen mit einem Gehalt an L-Arginin
US5759524A (en) * 1996-02-09 1998-06-02 The Procter & Gamble Company Photoprotective compositions
FR2775434B1 (fr) * 1998-02-27 2000-05-19 Oreal Compositions cosmetiques pour la photoprotection de la peau et/ou des cheveux a base d'un melange synergique de filtres et utilisations
DE10021468A1 (de) * 2000-05-04 2001-11-08 Basf Ag Verwendung von PARP-Inhibitoren in kosmetischen Zubereitungen
DE10062401A1 (de) * 2000-12-14 2002-06-20 Beiersdorf Ag Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA
CH696628A5 (de) * 2002-02-26 2007-08-31 Eprova Ag Verwendung von Folaten zur Herstellung einer Zubereitung geeignet zur Vorbeugung und Behandlung von Entzündungen und entzündungsassoziierter Krankheiten, im Speziellen zur Beeinflussung der
US20040191278A1 (en) 2003-03-31 2004-09-30 Christensen Flemming Kjaergaar Topical agent for application to the skin prior to luminous treatment
FR2894142B1 (fr) * 2005-12-05 2009-06-12 Oreal Utilisation de l'association du dipeptide tyrosine-arginine et de la niacimanide en tant qu'antagoniste de substance p
US8858968B2 (en) 2005-12-05 2014-10-14 L'oreal Use of tyrosine-arginine dipeptide and niacinamide as substance P antagonist
KR101275351B1 (ko) * 2010-06-29 2013-06-17 (주)아모레퍼시픽 노화방지용 화장료 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096712A1 (en) * 1970-06-29 1972-02-25 Giraux Georges Steroid/b group vitamin compsns - for prevention and treatment of skin-photosensitivity disorders
DE2242553A1 (de) * 1972-08-30 1974-03-07 Koehler Valentin Kosmetisches mittel
JPS59173124A (ja) * 1983-03-19 1984-10-01 Shiseido Co Ltd 乳化組成物
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques

Also Published As

Publication number Publication date
JPH0635387B2 (ja) 1994-05-11
ATE108993T1 (de) 1994-08-15
ES2061248T3 (es) 1994-12-01
EP0486632A1 (de) 1992-05-27
JPH05500230A (ja) 1993-01-21
WO1991019478A1 (de) 1991-12-26
DE4018964C1 (enExample) 1991-07-04
EP0486632B1 (de) 1994-07-27
AU7865791A (en) 1992-01-07
CA2059641A1 (en) 1991-12-14
DE59102350D1 (de) 1994-09-01

Similar Documents

Publication Publication Date Title
AU697584B2 (en) Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
AU5296593A (en) Concentrated mouthrinse for efficient delivery of antimicrobials
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
ZA91353B (en) Pharmaceutical and cosmetic compositions
MY129973A (en) Sulphonylbenzyl-substituted pyridones.
FI962022L (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
GR3003569T3 (enExample)
AU639615B2 (en) Pyrimidine derivative, production thereof, and androgen inhibitor
AU645092B2 (en) Anti-actinic agent
AU7270794A (en) Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
AU646439B2 (en) Novel retinoids
PH31320A (en) Fenbendazole formulations.
AU3049192A (en) An oxazoline derivative, its production and its use
PT910367E (pt) Uso de acetato de vitamina e
AU635870B2 (en) Hydrazone derivatives, processes for production thereof, and uses thereof
AU2302288A (en) 4-quinoline-3-carboxylic acid derivatives and their use as antibacterial agents
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
AU518781B2 (en) 7-OXO-l-AZABICYCLO 3. 2. 0 HEPT-2-ENE-2-CARBOXYLIC ACID DERIVATIVES
AU8844091A (en) Novel dihydroquinoline derivatives, pharmaceutical compositions and methods of use of dihidroquinoline derivatives as modulators of the arachidonic acid cascade
GR3004113T3 (enExample)
AU3070192A (en) Uses of 1,1,1,3,3,3-hexafluoropropane
AU5589294A (en) Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
AU5171279A (en) 2-amino or 2-thio derivatives of 4,5-diphenyl-oxazole
IL107242A0 (en) Derivatives of benzeneborinic acid, preparation thereof and use thereof as synthetic intermediates
AU7729691A (en) Carbamic acid derivatives, and their production and use